Canine Infectious Hepatitis Virus (CIHV) is a highly contagious viral infection that affects dogs. It is caused by the Canine Adenovirus Type 1 (CAV-1), a member of the Adenoviridae family. CIHV primarily targets the liver, but can also affect the kidneys, lungs, and eyes.
The virus is transmitted through direct contact with infected dogs or through contact with contaminated urine, feces, blood, or saliva. It can also spread through the air when an infected dog sneezes or coughs. CIHV is most commonly found in young puppies or unvaccinated adult dogs.
Symptoms of CIHV may vary depending on the severity of the infection. Mild cases may display only a slight illness or no symptoms at all. However, more severe cases can cause fever, lethargy, loss of appetite, vomiting, abdominal pain, jaundice, and in some cases, sudden death.
Treatment for CIHV is primarily focused on supportive care, as there are no specific antiviral drugs available to directly target the virus. Supportive treatment may include fluid therapy, nutritional support, and medications to alleviate symptoms. Vaccination is considered the most effective preventive measure against CIHV, with the vaccine offering protection against the virus and reducing the severity of symptoms if infection occurs.
In conclusion, Canine Infectious Hepatitis Virus is a highly contagious viral infection that primarily affects the liver of dogs. Vaccination and proper hygiene practices are essential in preventing the spread of this disease.
